Pharma and Healthcare Dealtracker: Q3 2024
Thought leadershipGet insights on Q3 2024 pharma and healthcare deals covers record-high domestic deals, PE trends, and capital market activity reshaping India's healthcare industry.
For more updates follow Grant Thornton Bharat on WhatsApp

The consumer and retail sector experienced significant growth in Q3 2024, driven by expanding direct-to-consumer brands and quick commerce. The momentum is expected to continue, fueled by the upcoming festive season. Investor confidence remains strong, with emerging opportunities across the sector. Our Consumer and Retail Dealtracker Q3 2024 edition provides an overview of the sector's performance, highlighting key trends, deal activity, and investor interest. It also analyses the growth drivers, challenges, and outlook, offering valuable insights into the country's evolving consumer and retail ecosystem.
Key insights from the Consumer and Retail Dealtracker Q3 2024:
Get insights on Q3 2024 pharma and healthcare deals covers record-high domestic deals, PE trends, and capital market activity reshaping India's healthcare industry.
Explore key insights from our Technology dealtracker Q3 2024, covering the latest tech investment trends, mergers, and acquisitions in the industry.
Explore our latest Real estate and REIT Q3 dealtracker 2024 highlights REIT market trends, real estate investments, and key sectoral insights.